NAT10 and Hutchinson-Gilford progeria syndrome: Interestingly, remodelin, a putative small molecule inhibitor of N-acetyl transferase 10 (NAT10), is a promising inhibitor which has shown preclinical efficiency in models of premature aging disease Hutchionson-Gilfords Progeria Syndrome (HGPS) [88].